Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Lansoprazole in Reflux Disease
NCT01135368Phase 4Completed
- Sponsor
- Takeda
- Start
- Jun 2002
- Primary completion
- Sep 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lansoprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda. Started Jun 2002; status: completed.
02
Drugs
lansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01135368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135368.